We are international
Donate
TEXT SIZE   


ASCO 2012: Dr. Moreau - A randomized phase II study of elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma
Philippe Moreau, MD
University Hospital
Nantes, France
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles